Who owns GlaxoSmithKline?

Key details on GlaxoSmithKline (Ticker: GSK)

Who owns GlaxoSmithKline?

Is GSK a good stock to own? Find out who bought GlaxoSmithKline, who sold GlaxoSmithKline (GSK) stock, and who holds a large position in GlaxoSmithKline.

Fund Name Number of Shares Share Valuation As Of
Dodge & Cox 38.59M $1.77B Sept. 30, 2014
Gruss & Co 25.33M $547.95M Sept. 30, 2012
Royal Bank of Canada 13.60M $625.68M Sept. 30, 2014
Bank of America Corporation 10.92M $502.22M Sept. 30, 2014
Hotchkis and Wiley Capital Management 10.80M $496.69M Sept. 30, 2014
STATE STREET CORPORATION 10.79M $496.19M Sept. 30, 2014
Fisher Investments 10.77M $460.10M Dec. 31, 2014
FMR 9.66M $444.03M Sept. 30, 2014
PRIMECAP Management Company 9.18M $490.37M March 31, 2014
T. Rowe Price Associates 9.04M $483.45M June 30, 2014
Wells Fargo & Company 8.52M $455.79M June 30, 2014
Inves 7.73M $355.14M Sept. 30, 2014
Allianz Asset Management AG 7.24M $387.09M June 30, 2014
Renaissance Technologies 6.83M $313.86M Sept. 30, 2014

Who sold GlaxoSmithKline?

Fund Name Date Sold Number of Shares Sold Share Valuation
Johnson Investment Counsel June 30, 2011 19.93M $947.34M
Allianz Global Investors of America June 30, 2011 10.17M $435.88M
Brandes Investment Partners Dec. 31, 2009 6.75M $285.39M